About
Pumpinheart is developing the PReduction device, an implantable ECG-gated diastolic pump aimed at treating Heart Failure with preserved Ejection Fraction (HFpEF) by reducing left atrial pressure during diastole to improve patient outcomes.
Explore Pumpinheart's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.